The global Dermal Fillers and Botulinum Toxin market is projected to reach US$ 26330 million by 2030 from an estimated US$ 14610 million in 2024, at a CAGR of 10.3% during 2024 and 2030.

Dermal Fillers and Botulinum Toxin Market

Dermal fillers help to diminish facial lines and restore volume and fullness in the face. Dermal fillers can be used to: plump thin lips, enhance shallow contours, soften facial creases and wrinkles and improve the appearance of recessed scars. Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.

Global key players of dermal fillers and botulinum toxin include AbbVie, Galderma, LG Life Sciences, etc. The top three players hold a share about 72%. Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 21% and 18%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermal Fillers and Botulinum Toxin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Dermal Fillers and Botulinum Toxin.

The Dermal Fillers and Botulinum Toxin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermal Fillers and Botulinum Toxin market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dermal Fillers and Botulinum Toxin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.

Market Segmentation

Scope of Dermal Fillers and Botulinum Toxin Market Report

Report Metric	Details
Report Name	Dermal Fillers and Botulinum Toxin Market
Accounted market size in 2024	an estimated US$ 14610 in million
Forecasted market size in 2030	US$ 26330 million
CAGR	10.3%
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Dermal Fillers Botulinum Toxin
Segment by Application	Cosmetic Medical
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Galderma, LG Life Sciences, Merz, Medytox, Hugel, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Elravie (Humedix), Cleviel (Pharma Research Products), Haohai Biological, Teoxane, Sinclair, Suneva Medical, CG Bio, SciVision Biotech, Prollenium, Bohus BioTech, Caregen, Ipsen, LIBP, US World Meds, Daewoong, JETEMA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Dermal Fillers and Botulinum Toxin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Dermal Fillers and Botulinum Toxin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dermal Fillers and Botulinum Toxin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.

FAQ for this report

How fast is Dermal Fillers and Botulinum Toxin Market growing?

Ans: The Dermal Fillers and Botulinum Toxin Market witnessing a CAGR of 10.3% during the forecast period 2024-2030.

What is the Dermal Fillers and Botulinum Toxin Market size in 2030?

Ans: The Dermal Fillers and Botulinum Toxin Market size in 2030 will be US$ 26330 million.

What is the market share of major companies in Dermal Fillers and Botulinum Toxin Market?

Ans: The top three players hold a share about 72%.

What is the Dermal Fillers and Botulinum Toxin Market share by region?

Ans: Americas is the largest market, has a share about 58%, followed by Europe and Asia-Pacific, with share 21% and 18%, separately.

Who are the main players in the Dermal Fillers and Botulinum Toxin Market report?

Ans: The main players in the Dermal Fillers and Botulinum Toxin Market are AbbVie, Galderma, LG Life Sciences, Merz, Medytox, Hugel, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Elravie (Humedix), Cleviel (Pharma Research Products), Haohai Biological, Teoxane, Sinclair, Suneva Medical, CG Bio, SciVision Biotech, Prollenium, Bohus BioTech, Caregen, Ipsen, LIBP, US World Meds, Daewoong, JETEMA

What are the Application segmentation covered in the Dermal Fillers and Botulinum Toxin Market report?

Ans: The Applications covered in the Dermal Fillers and Botulinum Toxin Market report are Cosmetic, Medical

What are the Type segmentation covered in the Dermal Fillers and Botulinum Toxin Market report?

Ans: The Types covered in the Dermal Fillers and Botulinum Toxin Market report are Dermal Fillers, Botulinum Toxin

1 Study Coverage

1.1 Dermal Fillers and Botulinum Toxin Product Introduction

1.2 Market by Type

1.2.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 Dermal Fillers

1.2.3 Botulinum Toxin

1.3 Market by Application

1.3.1 Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Cosmetic

1.3.3 Medical

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Dermal Fillers and Botulinum Toxin Market Size Estimates and Forecasts

2.1.1 Global Dermal Fillers and Botulinum Toxin Revenue 2019-2030

2.1.2 Global Dermal Fillers and Botulinum Toxin Sales 2019-2030

2.2 Dermal Fillers and Botulinum Toxin Market Size by Region: 2023 Versus 2030

2.3 Dermal Fillers and Botulinum Toxin Sales by Region (2019-2030)

2.3.1 Global Dermal Fillers and Botulinum Toxin Sales by Region: 2019-2024

2.3.2 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2025-2030)

2.3.3 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2019-2030)

2.4 Dermal Fillers and Botulinum Toxin Market Estimates and Projections by Region (2025-2030)

2.4.1 Global Dermal Fillers and Botulinum Toxin Revenue by Region: 2019-2024

2.4.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2025-2030)

2.4.3 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2019-2030)

3 Global Dermal Fillers and Botulinum Toxin by Manufacturers

3.1 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Sales

3.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Manufacturer (2019-2024)

3.1.2 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Manufacturer (2019-2024)

3.2 Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Revenue

3.2.1 Global Dermal Fillers and Botulinum Toxin Revenue by Manufacturer (2019-2024)

3.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturer (2019-2024)

3.3 Global Dermal Fillers and Botulinum Toxin Price by Manufacturer (2019-2024)

3.4 Competitive Landscape

3.4.1 Key Dermal Fillers and Botulinum Toxin Manufacturers Covered: Ranking by Revenue

3.4.2 Global Dermal Fillers and Botulinum Toxin Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.4.3 Global Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.5 Global Dermal Fillers and Botulinum Toxin Manufacturing Base Distribution, Product Type

3.5.1 Dermal Fillers and Botulinum Toxin Manufacturers Manufacturing Base Distribution, Headquarters

3.5.2 Manufacturers Dermal Fillers and Botulinum Toxin Product Type

3.5.3 Date of International Manufacturers Enter into Dermal Fillers and Botulinum Toxin Market

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 AbbVie

4.1.1 AbbVie Company Information

4.1.2 AbbVie Description, Business Overview

4.1.3 AbbVie Dermal Fillers and Botulinum Toxin Products Offered

4.1.4 AbbVie Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.1.5 AbbVie Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.1.6 AbbVie Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.1.7 AbbVie Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.1.8 AbbVie Recent Developments

4.2 Galderma

4.2.1 Galderma Company Information

4.2.2 Galderma Description, Business Overview

4.2.3 Galderma Dermal Fillers and Botulinum Toxin Products Offered

4.2.4 Galderma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.2.5 Galderma Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.2.6 Galderma Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.2.7 Galderma Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.2.8 Galderma Recent Developments

4.3 LG Life Sciences

4.3.1 LG Life Sciences Company Information

4.3.2 LG Life Sciences Description, Business Overview

4.3.3 LG Life Sciences Dermal Fillers and Botulinum Toxin Products Offered

4.3.4 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.3.5 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.3.6 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.3.7 LG Life Sciences Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.3.8 LG Life Sciences Recent Developments

4.4 Merz

4.4.1 Merz Company Information

4.4.2 Merz Description, Business Overview

4.4.3 Merz Dermal Fillers and Botulinum Toxin Products Offered

4.4.4 Merz Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.4.5 Merz Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.4.6 Merz Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.4.7 Merz Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.4.8 Merz Recent Developments

4.5 Medytox

4.5.1 Medytox Company Information

4.5.2 Medytox Description, Business Overview

4.5.3 Medytox Dermal Fillers and Botulinum Toxin Products Offered

4.5.4 Medytox Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.5.5 Medytox Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.5.6 Medytox Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.5.7 Medytox Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.5.8 Medytox Recent Developments

4.6 Hugel

4.6.1 Hugel Company Information

4.6.2 Hugel Description, Business Overview

4.6.3 Hugel Dermal Fillers and Botulinum Toxin Products Offered

4.6.4 Hugel Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.6.5 Hugel Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.6.6 Hugel Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.6.7 Hugel Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.6.8 Hugel Recent Development

4.7 Croma-Pharma

4.7.1 Croma-Pharma Company Information

4.7.2 Croma-Pharma Description, Business Overview

4.7.3 Croma-Pharma Dermal Fillers and Botulinum Toxin Products Offered

4.7.4 Croma-Pharma Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.7.5 Croma-Pharma Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.7.6 Croma-Pharma Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.7.7 Croma-Pharma Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.7.8 Croma-Pharma Recent Development

4.8 Beijing IMEIK

4.8.1 Beijing IMEIK Company Information

4.8.2 Beijing IMEIK Description, Business Overview

4.8.3 Beijing IMEIK Dermal Fillers and Botulinum Toxin Products Offered

4.8.4 Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.8.5 Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.8.6 Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.8.7 Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.8.8 Beijing IMEIK Recent Development

4.9 Bloomage Bio

4.9.1 Bloomage Bio Company Information

4.9.2 Bloomage Bio Description, Business Overview

4.9.3 Bloomage Bio Dermal Fillers and Botulinum Toxin Products Offered

4.9.4 Bloomage Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.9.5 Bloomage Bio Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.9.6 Bloomage Bio Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.9.7 Bloomage Bio Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.9.8 Bloomage Bio Recent Development

4.10 Elravie (Humedix)

4.10.1 Elravie (Humedix) Company Information

4.10.2 Elravie (Humedix) Description, Business Overview

4.10.3 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Products Offered

4.10.4 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.10.5 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.10.6 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.10.7 Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.10.8 Elravie (Humedix) Recent Development

4.11 Cleviel (Pharma Research Products)

4.11.1 Cleviel (Pharma Research Products) Company Information

4.11.2 Cleviel (Pharma Research Products) Description, Business Overview

4.11.3 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Products Offered

4.11.4 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.11.5 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.11.6 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.11.7 Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.11.8 Cleviel (Pharma Research Products) Recent Development

4.12 Haohai Biological

4.12.1 Haohai Biological Company Information

4.12.2 Haohai Biological Description, Business Overview

4.12.3 Haohai Biological Dermal Fillers and Botulinum Toxin Products Offered

4.12.4 Haohai Biological Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.12.5 Haohai Biological Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.12.6 Haohai Biological Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.12.7 Haohai Biological Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.12.8 Haohai Biological Recent Development

4.13 Teoxane

4.13.1 Teoxane Company Information

4.13.2 Teoxane Description, Business Overview

4.13.3 Teoxane Dermal Fillers and Botulinum Toxin Products Offered

4.13.4 Teoxane Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.13.5 Teoxane Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.13.6 Teoxane Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.13.7 Teoxane Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.13.8 Teoxane Recent Development

4.14 Sinclair

4.14.1 Sinclair Company Information

4.14.2 Sinclair Description, Business Overview

4.14.3 Sinclair Dermal Fillers and Botulinum Toxin Products Offered

4.14.4 Sinclair Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.14.5 Sinclair Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.14.6 Sinclair Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.14.7 Sinclair Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.14.8 Sinclair Recent Development

4.15 Suneva Medical

4.15.1 Suneva Medical Company Information

4.15.2 Suneva Medical Description, Business Overview

4.15.3 Suneva Medical Dermal Fillers and Botulinum Toxin Products Offered

4.15.4 Suneva Medical Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.15.5 Suneva Medical Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.15.6 Suneva Medical Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.15.7 Suneva Medical Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.15.8 Suneva Medical Recent Development

4.16 CG Bio

4.16.1 CG Bio Company Information

4.16.2 CG Bio Description, Business Overview

4.16.3 CG Bio Dermal Fillers and Botulinum Toxin Products Offered

4.16.4 CG Bio Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.16.5 CG Bio Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.16.6 CG Bio Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.16.7 CG Bio Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.16.8 CG Bio Recent Development

4.17 SciVision Biotech

4.17.1 SciVision Biotech Company Information

4.17.2 SciVision Biotech Description, Business Overview

4.17.3 SciVision Biotech Dermal Fillers and Botulinum Toxin Products Offered

4.17.4 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.17.5 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.17.6 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.17.7 SciVision Biotech Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.17.8 SciVision Biotech Recent Development

4.18 Prollenium

4.18.1 Prollenium Company Information

4.18.2 Prollenium Description, Business Overview

4.18.3 Prollenium Dermal Fillers and Botulinum Toxin Products Offered

4.18.4 Prollenium Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.18.5 Prollenium Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.18.6 Prollenium Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.18.7 Prollenium Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.18.8 Prollenium Recent Development

4.19 Bohus BioTech

4.19.1 Bohus BioTech Company Information

4.19.2 Bohus BioTech Description, Business Overview

4.19.3 Bohus BioTech Dermal Fillers and Botulinum Toxin Products Offered

4.19.4 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.19.5 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.19.6 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.19.7 Bohus BioTech Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.19.8 Bohus BioTech Recent Development

4.20 Caregen

4.20.1 Caregen Company Information

4.20.2 Caregen Description, Business Overview

4.20.3 Caregen Dermal Fillers and Botulinum Toxin Products Offered

4.20.4 Caregen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.20.5 Caregen Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.20.6 Caregen Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.20.7 Caregen Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.20.8 Caregen Recent Development

4.21 Ipsen

4.21.1 Ipsen Company Information

4.21.2 Ipsen Description, Business Overview

4.21.3 Ipsen Dermal Fillers and Botulinum Toxin Products Offered

4.21.4 Ipsen Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.21.5 Ipsen Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.21.6 Ipsen Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.21.7 Ipsen Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.21.8 Ipsen Recent Development

4.22 LIBP

4.22.1 LIBP Company Information

4.22.2 LIBP Description, Business Overview

4.22.3 LIBP Dermal Fillers and Botulinum Toxin Products Offered

4.22.4 LIBP Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.22.5 LIBP Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.22.6 LIBP Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.22.7 LIBP Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.22.8 LIBP Recent Development

4.23 US World Meds

4.23.1 US World Meds Company Information

4.23.2 US World Meds Description, Business Overview

4.23.3 US World Meds Dermal Fillers and Botulinum Toxin Products Offered

4.23.4 US World Meds Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.23.5 US World Meds Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.23.6 US World Meds Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.23.7 US World Meds Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.23.8 US World Meds Recent Development

4.24 Daewoong

4.24.1 Daewoong Company Information

4.24.2 Daewoong Description, Business Overview

4.24.3 Daewoong Dermal Fillers and Botulinum Toxin Products Offered

4.24.4 Daewoong Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.24.5 Daewoong Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.24.6 Daewoong Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.24.7 Daewoong Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.24.8 Daewoong Recent Development

4.25 JETEMA

4.25.1 JETEMA Company Information

4.25.2 JETEMA Description, Business Overview

4.25.3 JETEMA Dermal Fillers and Botulinum Toxin Products Offered

4.25.4 JETEMA Dermal Fillers and Botulinum Toxin Sales, Revenue and Gross Margin (2019-2024)

4.25.5 JETEMA Dermal Fillers and Botulinum Toxin Sales by Product in 2023

4.25.6 JETEMA Dermal Fillers and Botulinum Toxin Sales by Application in 2023

4.25.7 JETEMA Dermal Fillers and Botulinum Toxin Sales by Geographic Area in 2023

4.25.8 JETEMA Recent Development

5 Breakdown Data by Type

5.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2019-2030)

5.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024)

5.1.2 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2025-2030)

5.1.3 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2019-2030)

5.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2019-2030)

5.2.1 Global Dermal Fillers and Botulinum Toxin Revenue by Type (2019-2024)

5.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2025-2030)

5.2.3 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Type (2019-2030)

5.3 Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Dermal Fillers and Botulinum Toxin Sales by Application (2019-2030)

6.1.1 Global Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024)

6.1.2 Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2025-2030)

6.1.3 Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2019-2030)

6.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2019-2030)

6.2.1 Global Dermal Fillers and Botulinum Toxin Revenue by Application (2019-2024)

6.2.2 Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2025-2030)

6.2.3 Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Application (2019-2030)

6.3 Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Application (2019-2030)

7 North America

7.1 North America Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2019-2030

7.2 North America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country

7.2.1 North America Dermal Fillers and Botulinum Toxin Sales by Country (2019-2030)

7.2.2 North America Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2030)

7.3 North America Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024)

7.4 North America Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Market Facts & Figures by Region

8.2.1 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2019-2030)

8.2.2 Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2019-2030)

8.3 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024)

8.4 Asia-Pacific Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024)

9 Europe

9.1 Europe Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2019-2030

9.2 Europe Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country

9.2.1 Europe Dermal Fillers and Botulinum Toxin Sales by Country (2019-2030)

9.2.2 Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2030)

9.3 Europe Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024)

9.4 Europe Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024)

10 Latin America

10.1 Latin America Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2019-2030

10.2 Latin America Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country

10.2.1 Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2019-2030)

10.2.2 Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2030)

10.3 Latin America Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024)

10.4 Latin America Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Market Facts & Figures by Country

11.2.1 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2019-2030)

11.2.2 Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2030)

11.3 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024)

11.4 Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Dermal Fillers and Botulinum Toxin Supply Chain Analysis

12.2 Dermal Fillers and Botulinum Toxin Key Raw Materials and Upstream Suppliers

12.3 Dermal Fillers and Botulinum Toxin Clients Analysis

12.4 Dermal Fillers and Botulinum Toxin Sales Channel and Sales Model Analysis

12.4.1 Dermal Fillers and Botulinum Toxin Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Dermal Fillers and Botulinum Toxin Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Dermal Fillers and Botulinum Toxin Distributors

13 Market Dynamics

13.1 Dermal Fillers and Botulinum Toxin Industry Trends

13.2 Dermal Fillers and Botulinum Toxin Market Drivers

13.3 Dermal Fillers and Botulinum Toxin Market Challenges

13.4 Dermal Fillers and Botulinum Toxin Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Merz

Medytox

Bohus BioTech

Suneva Medical

Teoxane

SciVision Biotech

Ipsen S A

LIBP

US World Meds

HUGEL

Daewoong Co Ltd

Cleviel (Pharma Research Products)

List of Tables

Table 1. Global Dermal Fillers and Botulinum Toxin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Manufacturers of Dermal Fillers

Table 3. Major Manufacturers of Botulinum Toxin

Table 4. Global Dermal Fillers and Botulinum Toxin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Dermal Fillers and Botulinum Toxin Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Dermal Fillers and Botulinum Toxin Sales by Region (2019-2024) & (K Units)

Table 7. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Region (2025-2030) & (K Units)

Table 8. Global Dermal Fillers and Botulinum Toxin Revenue by Region (2019-2024) & (US$ Million)

Table 9. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 10. Global Dermal Fillers and Botulinum Toxin Sales by Manufacturer (2019-2024) & (K Units)

Table 11. Global Dermal Fillers and Botulinum Toxin Sales Share by Manufacturer (2019-2024)

Table 12. Dermal Fillers and Botulinum Toxin Revenue by Manufacturer (2019-2024) & (US$ Million)

Table 13. Dermal Fillers and Botulinum Toxin Revenue Share by Manufacturer (2019-2024)

Table 14. Key Manufacturers Dermal Fillers and Botulinum Toxin Price (2019-2024) & (USD/Unit)

Table 15. Ranking of Global Top Dermal Fillers and Botulinum Toxin Manufacturers by Revenue (US$ Million) in 2023

Table 16. Global Dermal Fillers and Botulinum Toxin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 17. Global Dermal Fillers and Botulinum Toxin by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dermal Fillers and Botulinum Toxin as of 2023)

Table 18. Dermal Fillers and Botulinum Toxin Manufacturers Manufacturing Base Distribution and Headquarters

Table 19. Manufacturers Dermal Fillers and Botulinum Toxin Product Type

Table 20. Date of International Manufacturers Enter into Dermal Fillers and Botulinum Toxin Market

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. AbbVie Company Information

Table 23. AbbVie Description and Business Overview

Table 24. AbbVie Dermal Fillers and Botulinum Toxin Product

Table 25. AbbVie Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 26. AbbVie Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 27. AbbVie Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 28. AbbVie Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 29. AbbVie Recent Development

Table 30. Galderma Company Information

Table 31. Galderma Description and Business Overview

Table 32. Galderma Dermal Fillers and Botulinum Toxin Product

Table 33. Galderma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 34. Galderma Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 35. Galderma Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 36. Galderma Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 37. Galderma Recent Development

Table 38. LG Life Sciences Company Information

Table 39. LG Life Sciences Description and Business Overview

Table 40. LG Life Sciences Dermal Fillers and Botulinum Toxin Product

Table 41. LG Life Sciences Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 42. LG Life Sciences Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 43. LG Life Sciences Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 44. LG Life Sciences Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 45. LG Life Sciences Recent Development

Table 46. Merz Company Information

Table 47. Merz Description and Business Overview

Table 48. Merz Dermal Fillers and Botulinum Toxin Product

Table 49. Merz Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 50. Merz Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 51. Merz Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 52. Merz Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 53. Merz Recent Development

Table 54. Medytox Company Information

Table 55. Medytox Description and Business Overview

Table 56. Medytox Dermal Fillers and Botulinum Toxin Product

Table 57. Medytox Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 58. Medytox Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 59. Medytox Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 60. Medytox Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 61. Medytox Recent Development

Table 62. Hugel Company Information

Table 63. Hugel Description and Business Overview

Table 64. Hugel Dermal Fillers and Botulinum Toxin Product

Table 65. Hugel Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 66. Hugel Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 67. Hugel Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 68. Hugel Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 69. Hugel Recent Development

Table 70. Croma-Pharma Company Information

Table 71. Croma-Pharma Description and Business Overview

Table 72. Croma-Pharma Dermal Fillers and Botulinum Toxin Product

Table 73. Croma-Pharma Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 74. Croma-Pharma Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 75. Croma-Pharma Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 76. Croma-Pharma Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 77. Croma-Pharma Recent Development

Table 78. Beijing IMEIK Company Information

Table 79. Beijing IMEIK Description and Business Overview

Table 80. Beijing IMEIK Dermal Fillers and Botulinum Toxin Product

Table 81. Beijing IMEIK Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 82. Beijing IMEIK Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 83. Beijing IMEIK Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 84. Beijing IMEIK Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 85. Beijing IMEIK Recent Development

Table 86. Bloomage Bio Company Information

Table 87. Bloomage Bio Description and Business Overview

Table 88. Bloomage Bio Dermal Fillers and Botulinum Toxin Product

Table 89. Bloomage Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Bloomage Bio Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 91. Bloomage Bio Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 92. Bloomage Bio Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 93. Bloomage Bio Recent Development

Table 94. Elravie (Humedix) Company Information

Table 95. Elravie (Humedix) Description and Business Overview

Table 96. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Product

Table 97. Elravie (Humedix) Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Elravie (Humedix) Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 99. Elravie (Humedix) Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 100. Elravie (Humedix) Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 101. Elravie (Humedix) Recent Development

Table 102. Cleviel (Pharma Research Products) Company Information

Table 103. Cleviel (Pharma Research Products) Description and Business Overview

Table 104. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Product

Table 105. Cleviel (Pharma Research Products) Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 106. Cleviel (Pharma Research Products) Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 107. Cleviel (Pharma Research Products) Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 108. Cleviel (Pharma Research Products) Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 109. Cleviel (Pharma Research Products) Recent Development

Table 110. Haohai Biological Company Information

Table 111. Haohai Biological Description and Business Overview

Table 112. Haohai Biological Dermal Fillers and Botulinum Toxin Product

Table 113. Haohai Biological Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 114. Haohai Biological Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 115. Haohai Biological Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 116. Haohai Biological Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 117. Haohai Biological Recent Development

Table 118. Teoxane Company Information

Table 119. Teoxane Description and Business Overview

Table 120. Teoxane Dermal Fillers and Botulinum Toxin Product

Table 121. Teoxane Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 122. Teoxane Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 123. Teoxane Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 124. Teoxane Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 125. Teoxane Recent Development

Table 126. Sinclair Company Information

Table 127. Sinclair Description and Business Overview

Table 128. Sinclair Dermal Fillers and Botulinum Toxin Product

Table 129. Sinclair Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. Sinclair Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 131. Sinclair Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 132. Sinclair Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 133. Sinclair Recent Development

Table 134. Suneva Medical Company Information

Table 135. Suneva Medical Description and Business Overview

Table 136. Suneva Medical Dermal Fillers and Botulinum Toxin Product

Table 137. Suneva Medical Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Suneva Medical Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 139. Suneva Medical Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 140. Suneva Medical Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 141. Suneva Medical Recent Development

Table 142. CG Bio Company Information

Table 143. CG Bio Description and Business Overview

Table 144. CG Bio Dermal Fillers and Botulinum Toxin Product

Table 145. CG Bio Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 146. CG Bio Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 147. CG Bio Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 148. CG Bio Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 149. CG Bio Recent Development

Table 150. SciVision Biotech Company Information

Table 151. SciVision Biotech Description and Business Overview

Table 152. SciVision Biotech Dermal Fillers and Botulinum Toxin Product

Table 153. SciVision Biotech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 154. SciVision Biotech Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 155. SciVision Biotech Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 156. SciVision Biotech Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 157. SciVision Biotech Recent Development

Table 158. Prollenium Company Information

Table 159. Prollenium Description and Business Overview

Table 160. Prollenium Dermal Fillers and Botulinum Toxin Product

Table 161. Prollenium Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 162. Prollenium Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 163. Prollenium Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 164. Prollenium Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 165. Prollenium Recent Development

Table 166. Bohus BioTech Company Information

Table 167. Bohus BioTech Description and Business Overview

Table 168. Bohus BioTech Dermal Fillers and Botulinum Toxin Product

Table 169. Bohus BioTech Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 170. Bohus BioTech Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 171. Bohus BioTech Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 172. Bohus BioTech Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 173. Bohus BioTech Recent Development

Table 174. Caregen Company Information

Table 175. Caregen Description and Business Overview

Table 176. Caregen Dermal Fillers and Botulinum Toxin Product

Table 177. Caregen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 178. Caregen Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 179. Caregen Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 180. Caregen Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 181. Caregen Recent Development

Table 182. Ipsen Company Information

Table 183. Ipsen Description and Business Overview

Table 184. Ipsen Dermal Fillers and Botulinum Toxin Product

Table 185. Ipsen Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 186. Ipsen Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 187. Ipsen Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 188. Ipsen Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 189. Ipsen Recent Development

Table 190. LIBP Company Information

Table 191. LIBP Description and Business Overview

Table 192. LIBP Dermal Fillers and Botulinum Toxin Product

Table 193. LIBP Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 194. LIBP Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 195. LIBP Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 196. LIBP Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 197. LIBP Recent Development

Table 198. US World Meds Company Information

Table 199. US World Meds Description and Business Overview

Table 200. US World Meds Dermal Fillers and Botulinum Toxin Product

Table 201. US World Meds Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 202. US World Meds Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 203. US World Meds Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 204. US World Meds Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 205. US World Meds Recent Development

Table 206. Daewoong Company Information

Table 207. Daewoong Description and Business Overview

Table 208. Daewoong Dermal Fillers and Botulinum Toxin Product

Table 209. Daewoong Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 210. Daewoong Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 211. Daewoong Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 212. Daewoong Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 213. Daewoong Recent Development

Table 214. JETEMA Company Information

Table 215. JETEMA Description and Business Overview

Table 216. JETEMA Dermal Fillers and Botulinum Toxin Product

Table 217. JETEMA Dermal Fillers and Botulinum Toxin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 218. JETEMA Sales Proportion of Dermal Fillers and Botulinum Toxin by Product in 2023

Table 219. JETEMA Sales Proportion of Dermal Fillers and Botulinum Toxin by Application in 2023

Table 220. JETEMA Sales Proportion of Dermal Fillers and Botulinum Toxin by Geographic Area in 2023

Table 221. JETEMA Recent Development

Table 222. Global Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024) & (K Units)

Table 223. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Type (2025-2030) & (K Units)

Table 224. Global Dermal Fillers and Botulinum Toxin Revenue by Type (2019-2024) & (US$ Million)

Table 225. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 226. Global Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024) & (K Units)

Table 227. Global Dermal Fillers and Botulinum Toxin Sales Forecast by Application (2025-2030) & (K Units)

Table 228. Global Dermal Fillers and Botulinum Toxin Revenue by Application (2019-2024) & (US$ Million)

Table 229. Global Dermal Fillers and Botulinum Toxin Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 230. North America Dermal Fillers and Botulinum Toxin Sales by Country (2019-2024) & (K Units)

Table 231. North America Dermal Fillers and Botulinum Toxin Sales by Country (2025-2030) & (K Units)

Table 232. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2024) & (US$ Million)

Table 233. North America Dermal Fillers and Botulinum Toxin Revenue by Country (2025-2030) & (US$ Million)

Table 234. North America Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024) & (K Units)

Table 235. North America Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024) & (K Units)

Table 236. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2019-2024) & (K Units)

Table 237. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales by Region (2025-2030) & (K Units)

Table 238. Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2019-2030) & (US$ Million)

Table 239. Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue by Region (2025-2030) & (US$ Million)

Table 240. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024) & (K Units)

Table 241. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024) & (K Units)

Table 242. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2019-2024) & (K Units)

Table 243. Europe Dermal Fillers and Botulinum Toxin Sales by Country (2025-2030) & (K Units)

Table 244. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2024) & (US$ Million)

Table 245. Europe Dermal Fillers and Botulinum Toxin Revenue by Country (2025-2030) & (US$ Million)

Table 246. Europe Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024) & (K Units)

Table 247. Europe Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024) & (K Units)

Table 248. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2019-2024) & (K Units)

Table 249. Latin America Dermal Fillers and Botulinum Toxin Sales by Country (2025-2030) & (K Units)

Table 250. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2024) & (US$ Million)

Table 251. Latin America Dermal Fillers and Botulinum Toxin Revenue by Country (2025-2030) & (US$ Million)

Table 252. Latin America Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024) & (K Units)

Table 253. Latin America Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024) & (K Units)

Table 254. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2019-2024) & (K Units)

Table 255. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Country (2025-2030) & (K Units)

Table 256. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2019-2024) & (US$ Million)

Table 257. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue by Country (2025-2030) & (US$ Million)

Table 258. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Type (2019-2024) & (K Units)

Table 259. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales by Application (2019-2024) & (K Units)

Table 260. Dermal Fillers and Botulinum Toxin Key Raw Materials, Industry Status and Trend

Table 261. Dermal Fillers and Botulinum Toxin Key Raw Materials and Upstream Suppliers

Table 262. Dermal Fillers and Botulinum Toxin Clients Status and Trend

Table 263. Dermal Fillers and Botulinum Toxin Typical Clients

Table 264. Dermal Fillers and Botulinum Toxin Distributors

Table 265. Dermal Fillers and Botulinum Toxin Market Trends

Table 266. Dermal Fillers and Botulinum Toxin Market Drivers

Table 267. Dermal Fillers and Botulinum Toxin Market Challenges

Table 268. Dermal Fillers and Botulinum Toxin Market Restraints

Table 269. Research Programs/Design for This Report

Table 270. Key Data Information from Secondary Sources

Table 271. Key Data Information from Primary Sources

List of Figures

Figure 1. Dermal Fillers and Botulinum Toxin Product Picture

Figure 2. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Type in 2023 & 2030

Figure 3. Dermal Fillers Product Picture

Figure 4. Botulinum Toxin Product Picture

Figure 5. Global Dermal Fillers and Botulinum Toxin Sales Market Share by Application in 2023 & 2030

Figure 6. Cosmetic Examples

Figure 7. Medical Examples

Figure 8. Dermal Fillers and Botulinum Toxin Report Years Considered

Figure 9. Global Dermal Fillers and Botulinum Toxin Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 10. Global Dermal Fillers and Botulinum Toxin Market Size 2019-2030 (US$ Million)

Figure 11. Global Dermal Fillers and Botulinum Toxin Sales 2019-2030 (K Units)

Figure 12. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Region (2019-2030)

Figure 13. Global Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2019-2030)

Figure 14. Global Dermal Fillers and Botulinum Toxin Sales Share by Manufacturer in 2023

Figure 15. Dermal Fillers and Botulinum Toxin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 16. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Type (2019-2030)

Figure 17. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Type (2019-2030)

Figure 18. Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Type (2019-2024) & (USD/Unit)

Figure 19. Global Dermal Fillers and Botulinum Toxin Sales Market Share Forecast by Application (2019-2030)

Figure 20. Global Dermal Fillers and Botulinum Toxin Revenue Market Share Forecast by Application (2019-2030)

Figure 21. Dermal Fillers and Botulinum Toxin Average Selling Price (ASP) by Application (2019-2024) & (USD/Unit)

Figure 22. North America Dermal Fillers and Botulinum Toxin Revenue 2019-2030 (US$ Million)

Figure 23. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2019-2024)

Figure 24. North America Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2019-2024)

Figure 25. Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue 2019-2030 (US$ Million)

Figure 26. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Region (2019-2030)

Figure 27. Asia-Pacific Dermal Fillers and Botulinum Toxin Revenue Market Share by Region (2019-2030)

Figure 28. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2019-2024)

Figure 29. Asia-Pacific Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2019-2024)

Figure 30. Europe Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2019-2030 (US$ Million)

Figure 31. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2019-2030)

Figure 32. Europe Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2019-2030)

Figure 33. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2019-2024)

Figure 34. Europe Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2019-2024)

Figure 35. Latin America Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2019-2030 (US$ Million)

Figure 36. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2019-2030)

Figure 37. Latin America Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2019-2024)

Figure 38. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2019-2024)

Figure 39. Latin America Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2019-2024)

Figure 40. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Growth Rate 2019-2030 (US$ Million)

Figure 41. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Country (2019-2030)

Figure 42. Middle East and Africa Dermal Fillers and Botulinum Toxin Revenue Market Share by Country (2019-2030)

Figure 43. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Type (2019-2024)

Figure 44. Middle East and Africa Dermal Fillers and Botulinum Toxin Sales Market Share by Application (2019-2024)

Figure 45. Dermal Fillers and Botulinum Toxin Supply Chain (Upstream and Downstream Market)

Figure 46. Global Production Market Share of Dermal Fillers and Botulinum Toxin Raw Materials by Region in 2023

Figure 47. Dermal Fillers and Botulinum Toxin Distribution Channels

Figure 48. Global Dermal Fillers and Botulinum Toxin Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 49. Global Dermal Fillers and Botulinum Toxin Percentage 2019-2030: Online Sales VS Offline Sales

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions